Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Jazz Pharmaceuticals plc shares valued at $55,000 were sold by COZADD BRUCE C on Jun 03 ’25. At $110.00 per share, COZADD BRUCE C sold 500 shares. The insider’s holdings dropped to 437,973 shares worth approximately $47.41 million following the completion of this transaction.
Also, COZADD BRUCE C sold 500 shares, netting a total of over 53,950 in proceeds. Following the sale of shares at $107.90 each, the insider now holds 438,473 shares.
Before that, COZADD BRUCE C had added 1,000 shares to its account. In a trade valued at $108,950, the Officer bought Jazz Pharmaceuticals plc shares for $108.95 each.
As published in a research note from UBS on March 07, 2025, Jazz Pharmaceuticals plc [JAZZ] has been rated up from a Neutral to a Buy and the price target has been revised to $179 from $145. Analysts at Cantor Fitzgerald downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late February. As of February 13, 2025, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for JAZZ. Earlier on December 12, 2024, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for JAZZ stock which previously was a “an Equal-weight”.
Analyzing JAZZ Stock Performance
On last trading session,, Jazz Pharmaceuticals plc [NASDAQ: JAZZ] rose 1.11% to $108.24. The stock’s lowest price that day was $106.56, but it reached a high of $109.43 in the same session. During the last five days, there has been a drop of approximately -2.05%. Over the course of the year, Jazz Pharmaceuticals plc shares have dropped approximately -12.11%. Shares of the company reached a 52-week high of $148.06 on 02/26/25 and a 52-week low of $95.49 on 04/09/25.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 106.72, which, if violated, would cause prices to drop to 105.21. In the upper region, resistance lies at 109.59. The next price resistance is at 110.95. RSI (Relative Strength Index) is 47.19 on the 14-day chart, showing neutral technical sentiment.
Is Jazz Pharmaceuticals plc subject to short interest?
Stocks of Jazz Pharmaceuticals plc saw a sharp rise in short interest on 2025-05-30 jumping by 0.37 million shares to 5.71 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 5.35 million shares. A jump of 6.41% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.27 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.27.
Which companies own the most shares of Jazz Pharmaceuticals plc (JAZZ)?
In terms of Jazz Pharmaceuticals plc share price expectations, FactSet research, analysts set an average price target of 215 in the next 12 months, up nearly 100.84% from the previous closing price of $107.05. Analysts anticipate Jazz Pharmaceuticals plc stock to reach 230 by 2025, with the lowest price target being 200. In spite of this, 6 analysts ranked Jazz Pharmaceuticals plc stock as Buy at the end of 2025. On June 05, 2024, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $169.
